These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 3502324

  • 21. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
    McGeer PL, Schwab C, Parent A, Doudet D.
    Ann Neurol; 2003 Nov; 54(5):599-604. PubMed ID: 14595649
    [Abstract] [Full Text] [Related]

  • 22. [The neurotoxic effect of MPTP and its mechanisms].
    Xu XJ.
    Sheng Li Ke Xue Jin Zhan; 1988 Oct; 19(4):310-4. PubMed ID: 3074503
    [No Abstract] [Full Text] [Related]

  • 23. Mitochondria covered with a net of parallel and latticed filaments in nigral neurons of monkeys with experimental parkinsonism.
    Nakamura H, Kato S, Tanaka J.
    Acta Neuropathol; 1989 Oct; 77(5):489-93. PubMed ID: 2785741
    [Abstract] [Full Text] [Related]

  • 24. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y.
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [Abstract] [Full Text] [Related]

  • 25. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY, Jang EH, Park CS, Kang JH.
    Free Radic Biol Med; 2005 Mar 15; 38(6):806-16. PubMed ID: 15721991
    [Abstract] [Full Text] [Related]

  • 26. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.
    Tanaka J, Nakamura H, Honda S, Takada K, Kato S.
    Acta Neuropathol; 1988 Jun 19; 75(4):370-6. PubMed ID: 3259063
    [Abstract] [Full Text] [Related]

  • 32. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
    Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF.
    Exp Neurol; 1999 May 19; 157(1):142-9. PubMed ID: 10222117
    [Abstract] [Full Text] [Related]

  • 33. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 19; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 34. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
    Heise CE, Teo ZC, Wallace BA, Ashkan K, Benabid AL, Mitrofanis J.
    Anat Embryol (Berl); 2005 Nov 19; 210(4):287-302. PubMed ID: 16237536
    [Abstract] [Full Text] [Related]

  • 35. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 36. [Etiopathogeny of Parkinson disease. The MPTP revolution].
    Sampaio C, Castro Caldas A.
    Acta Med Port; 1988 Jun 01; 1(4-6):304-7. PubMed ID: 3073646
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Skin colour, MPTP, and Parkinson's disease.
    Lerner MR, Goldman RS.
    Lancet; 1987 Jul 25; 2(8552):212. PubMed ID: 2885659
    [No Abstract] [Full Text] [Related]

  • 39. Alteration of monkey retinal oscillatory potentials after MPTP injection.
    Harnois C, Marcotte G, Bédard PJ.
    Doc Ophthalmol; 1987 Dec 25; 67(4):363-9. PubMed ID: 3502624
    [Abstract] [Full Text] [Related]

  • 40. Melanin affinity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, an inducer of chronic parkinsonism in humans.
    Lydén A, Bondesson U, Larsson BS, Lindquist NG.
    Acta Pharmacol Toxicol (Copenh); 1983 Nov 25; 53(5):429-32. PubMed ID: 6606936
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.